NEW YORK (GenomeWeb) – Cofactor Genomics has recently received a $1.5 million Phase II SBIR grant from the National Institutes of Health to further develop a circular RNA enrichment technology.

Circular RNA is noncoding, present in the cytoplasm, plays a role in neuronal development, and can serve as a biomarker for psychiatric disorders, according to Cofactor. In addition, circRNAs are present in lower abundance than other RNA molecules, and share sequence homology with mRNA, so they are difficult to isolate from total RNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.